Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

INSP Feb 2022 170.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
54.900.00 (0.00%)
At close: 5:28PM EDT
Advertisement
Full screen
Previous Close54.90
Open54.90
Bid80.80
Ask83.60
Strike170.00
Expire Date2022-02-18
Day's Range54.90 - 54.90
Contract RangeN/A
Volume1
Open Interest1
  • GlobeNewswire

    Inspire Medical Systems, Inc. to Present at the Piper Sandler 33rd Annual Healthcare Conference

    MINNEAPOLIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the virtual Piper Sandler 33rd Annual Healthcare Conference on Wednesday, December 1, 2021. Inspire is scheduled to present at 3:30 p.m. Eastern Time. The presentation will

  • GlobeNewswire

    Inspire Medical Systems, Inc. Provides Update on 2022 Ambulatory Surgical Center Reimbursement Levels

    MINNEAPOLIS, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, is providing an update on the 2022 Reimbursement payment rates for Inspire procedures performed in Ambulatory Surgical Centers (ASCs). The Centers for Medicare and Medicaid Services (CMS) today published updated addendum files fo

  • Motley Fool

    Inspire Medical Systems, inc (INSP) Q3 2021 Earnings Call Transcript

    Joining me are Tim Herbert, President and Chief Executive Officer; and Rick Buchholz, Chief Financial Officer. On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including, without limitation, those relating to our operations, financial results and financial condition, investments in our business, continued effects of the COVID-19 pandemic, full year 2021 financial and operational outlook and improvements in market access are based upon our current estimates and various assumptions.

Advertisement
Advertisement